Oncolytics Biotech
ONCY
#9623
Rank
HK$0.79 B
Marketcap
HK$6.65
Share price
2.50%
Change (1 day)
-31.66%
Change (1 year)

EPS for Oncolytics Biotech (ONCY)

EPS in 2026 (TTM): -HK$1.81

According to Oncolytics Biotech 's latest financial reports the company's current EPS (TTM) is -HK$1.82. In 2025 the company made an earnings per share (EPS) of -HK$2.35 a decrease over its 2024 EPS that were of -HK$1.56.

EPS history for Oncolytics Biotech from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.81-23.1%
2025-HK$2.3550.69%
2024-HK$1.56-14.56%
2023-HK$1.83-0.2%
2022-HK$1.83-22.57%
2021-HK$2.36-12.45%
2020-HK$2.70-60.83%
2019-HK$6.8953.89%
2018-HK$4.48-20.77%
2017-HK$5.655.46%
2016-HK$5.3615.45%
2015-HK$4.64-60.01%
2014-HK$11.61-36.9%
2013-HK$18.40-49.09%
2012-HK$36.1422.91%
2011-HK$29.4123.34%
2010-HK$23.842.06%
2009-HK$23.3610.5%
2008-HK$21.14-28.1%
2007-HK$29.41-259.86%
2006HK$18.400.02%
2005HK$18.39-5.08%
2004HK$19.3861.55%
2003HK$11.99110.82%
2002HK$5.69-9.06%
2001HK$6.26-185.76%
2000-HK$7.29104.56%
1999-HK$3.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
HK$221.31-12,290.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.91-1,637.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-HK$95.82 5,177.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-HK$16.07 784.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$10.74-691.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-HK$6.59 262.79%๐Ÿ‡บ๐Ÿ‡ธ USA